Archives of Medical Research
Volume 35, Issue 6 , Pages 465-479 , November 2004

Molecular mechanisms involved in the pathogenesis of septic shock

  • Lucia Nikolaia López-Bojórquez

      Affiliations

    • Departamento de Biología Celular, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico, D.F., Mexico
    • Corresponding Author InformationAddress reprint requests to: Lucia Nikolaia Lopez-Bojorquez. Laboratorio D-03 Fisiología Evolutiva, Instituto de Neurobiología. Km 14.5 Carretera Querétaro-San Luis Potosí. Campus UNAM-UAQ, Juriquilla, Querétaro, México 76230 Universitaria. 32170 México, D.F. Phone: (+52) (55) 622-4068; FAX: (+52) (55) 622-4038
    • ,
  • Alejandro Zentella Dehesa

      Affiliations

    • Departamento de Biología Celular, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico, D.F., Mexico
    • ,
  • Gustavo Reyes-Terán

      Affiliations

    • Servicio de Infectología, Unidad de Investigación, Instituto Nacional de Enfermedades Respiratorias, México, D.F., D.F. Mexico

References 

  1. Matzinger P. The danger model: a renewed sense of self. Science. 2002;296(5566):301–305
  2. Levy MM FM, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, et al. International Sepsis Definitions Conference. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003;29(4):530–538
  3. Friedman GSE, Vincent JL. Has the mortality of septic shock changed with time. Crit Care Med. 1998;26(12):2078–2086
  4. Sifuentes-Osornio JG-AM, Ponce de Leon-Garduno LA, Guerrero-Almeida ML. Trends for bacteremia and risk factors for death in a tertiary hospital in Mexico City. 1981-1992. Gac Med Mex. 2001;137(3):191–202
  5. Zamora-Castorena S, Murgia-de-Sierra MT. Five year experience with neonatal sepsis in a pediatric center. Rev Invest Clin. 1998;50(6):463–470
  6. Murphy K, Haudek SB, Thompson M, Giroir BP. Molecular biology of septic shock. New Horiz. 1998;6(2):181–193
  7. Fantuzzi L, Puddu P, Varano B, Del Corno M, Belardelli F, Gessani S. IFN-alpha and IL-18 exert opposite regulatory effects on the IL-12 receptor expression and IL-12-induced IFN-gamma production in mouse macrophages: novel pathways in the regulation of the inflammatory response of macrophages. J Leukoc Biol. 2000;68(5):707–714
  8. Tufano MA, Cipollaro de l'Ero G, Ianniello R, Galdiero M, Galdiero F. Protein A and other surface components of Staphylococcus aureus stimulate production of IL-1 alpha, IL-4, IL-6, TNF and IFN-gamma. Eur Cytokine Netw. 1991;2(5):361–366
  9. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature. 1996;383:787–793
  10. Nathan CF. Macrophage activation: some questions. Ann Inst Pasteur Immunol. 1986;137C(3):345–351
  11. Aderem A. How to eat something bigger than your head. Cell. 2002;110(1):5–8
  12. Abrahams VM, Cambridge G, Lydyard PM, Edwards JC. Induction of tumor necrosis factor alpha production by adhered human monocytes: a key role for Fcgamma receptor type IIIa in rheumatoid arthritis. Arthritis Rheum. 2000;43(3):608–616
  13. Lebron F, Vassallo R, Puri V, Limper AH. Pneumocystis carinii cell wall beta-glucans initiate macrophage inflammatory responses through NF-kB activation. J Biol Chem. 2003;25:25
  14. Fenton MJ, Golenbock DT. LPS-binding proteins and receptors. J Leukoc Biol. 1998;64(1):25–32
  15. Iwahashi H, Takeshita A, Hanazawa S. Prostaglandin E2 stimulates AP-1-mediated CD14 expression in mouse macrophages via cyclic AMP-dependent protein kinase A. J Immunol. 2000;164(10):5403–5408
  16. Hampton RY, Raetz CR. Macrophage catabolism of lipid A is regulated by endotoxin stimulation. J Biol Chem. 1991;266(29):19499–19509
  17. Nathan C, Sporn M. Cytokines in context. J Cell Biol. 1991;113(5):981–986
  18. Hamann L, Schumann RR, Flad HD, Brade L, Rietschel ET, Ulmer AJ. Binding of lipopolysaccharide (LPS) to CHO cells does not correlate with LPS-induced NF-kappaB activation. Eur J Immunol. 2000;30(1):211–216
  19. Golenbock DT, Fenton MJ. Extolling the diversity of bacterial endotoxins. Nat Immunol. 2001;2(4):286–268
  20. Guha M, O'Connell MA, Pawlinski R, Hollis A, McGovern P, Yan Stern D, et al. Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood. 2001;98(5):1429–1439
  21. Picard C, Puel A, Bonnet M, Ku CL, Bustamante J, Yang K, et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science. 2003;299(5615):2076–2079
  22. Zhang FX, Kirschning CJ, Mancinelli R, Xu XP, Jin Y, Faure E, et al. Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J Biol Chem. 1999;274(12):7611–7614
  23. Guo F, Wu S. IRAK-2 and PI 3-kinase synergistically activate NF-kappaB and AP-1. Inflammation. 2000;24(4):305–316
  24. Takeuchi O, Akira S. Toll-like receptors; their physiological role and signal transduction system. Int Immunopharmacol. 2001;1(4):625–635
  25. Akira S. Toll-like receptors: lessons from knockout mice. Biochem Soc Trans. 2000;28(5):551–556
  26. Werts C, Tapping RI, Mathison JC, Chuang TH, Kravchenko V, Saint Girons I, et al. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol. 2001;2(4):346–352
  27. Medzhitov R. CpG DNA: security code for host defense. Nat Immunol. 2001;2(1):15–16
  28. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 2001;413(6857):732–738
  29. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, et al. A Toll-like receptor recognizes bacterial DNA. Nature. 2000;408(6813):740–745
  30. Modlin RL. Activation of toll-like receptors by microbial lipoproteins: role in host defense. J Allergy Clin Immunol. 2001;108(4 Suppl):S104–S106
  31. Kengatharan KM, De Kimpe S, Robson C, Foster SJ, Thiemermann C. Mechanism of gram-positive shock: identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure. J Exp Med. 1998;188(2):305–315
  32. Dokter WH, Dijkstra AJ, Koopmans SB, Mulder AB, Stulp BK, Halie MR, et al. G(Anh)MTetra, a natural bacterial cell wall breakdown product, induces interleukin-1 beta and interleukin-6 expression in human cytokine expression. J Biol Chem. 1994;269(6):4201–4206
  33. Yuan Q, Zhao F, Chung SW, Fan P, Sultzer BM, Kan YW, et al. Dominant negative down-regulation of endotoxin-induced tumor necrosis factor alpha production by Lps(d)/Ran. Proc Natl Acad Sci USA. 2000;97(6):2852–2857
  34. Lien E, Means TK, Heine H, Yoshimura A, Kusumoto S, Fukase K, et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest. 2000;105(4):497–504
  35. Bave U, Vallin H, Alm GV, Ronnblom L. Activation of natural interferon-alpha producing cells by apoptotic U937 cells combined with lupus IgG and its regulation by cytokines. J Autoimmun. 2001;17(1):71–80
  36. Gingras MC, Lapillonne H, Margolin JF. TREM-1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid development. Mol Immunol. 2002;38(11):817–824
  37. Jiang Q, Akashi S, Miyake K, Petty HR. Lipopolysaccharide induces physical proximity between CD14 and toll- like receptor 4 (TLR4) prior to nuclear translocation of NF-kappa B. J Immunol. 2000;165(7):3541–3544
  38. Bouchon A, Facchetti F, Weigand MA, Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 2001;410(6832):1103–1107
  39. Horng T, Medzhitov R. Drosophila MyD88 is an adapter in the Toll signaling pathway. Proc Natl Acad Sci USA. 2001;98(22):12654–12658
  40. Akira S, Hoshino K, Kaisho T. The role of Toll-like receptors and MyD88 in innate immune responses. J Endotoxin Res. 2000;6(5):383–387
  41. Aliprantis AO, Yang RB, Weiss DS, Godowski P, Zychlinsky A. The apoptotic signaling pathway activated by Toll-like receptor-2. EMBO J. 2000;19(13):3325–3336
  42. Baeuerle PA. Pro-inflammatory signaling: last pieces in the NF-kappaB puzzle?. Curr Biol. 1998;8(1):R19–R22
  43. Caamano J, Hunter CA. NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions. Clin Microbiol Rev. 2002;15(3):414–429
  44. Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol. 2002;3(3):221–227
  45. Gilmore TD. The Rel/NF-kappaB signal transduction pathway: introduction. Oncogene. 1999;18(49):6842–6844
  46. Chen FE, Ghosh G. Regulation of DNA binding by Rel/NF-kappaB transcription factors: structural views. Oncogene. 1999;18(49):6845–6852
  47. Mercurio F, Manning AM. Multiple signals converging on NF-kappaB. Curr Opin Cell Biol. 1999;11(2):226–232
  48. Lavon I, Goldberg I, Amit S, Landsman L, Jung S, Tsuberi BZ, et al. High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-kappaB activation. Nat Med. 2000;6(5):573–577
  49. Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest. 2001;107(2):135–142
  50. Baldwin AS. Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest. 2001;107(1):3–6
  51. Liu SF, Ye X, Malik AB. Inhibition of NF-kappaB activation by pyrrolidine dithiocarbamate prevents In vivo expression of proinflammatory genes. Circulation. 1999;100(12):1330–1337
  52. Bohuslav J, Kravchenko VV, Parry GC, Erlich JH, Gerondakis S, Mackman N, et al. Regulation of an essential innate immune response by the p50 subunit of NF-kappaB. J Clin Invest. 1998;102(9):1645–1652
  53. Oliver FJ, Menissier-de Murcia J, Nacci C, Decker P, Andriantsitohaina R, Muller S, et al. Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J. 1999;18(16):4446–4454
  54. Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest. 2001;107(1):7–11
  55. Nathan CF. Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J Clin Invest. 1987;80(6):1550–1560
  56. Beutler B, Mahoney J, Le Trang N, Pekala P, Cerami A. Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells. J Exp Med. 1985;161(5):984–995
  57. Beutler B, Cerami A. The biology of cachectin/TNF—a primary mediator of the host response. Annu Rev Immunol. 1989;7:625–655
  58. Jue DM, Sherry B, Luedke C, Manogue KR, Cerami A. Processing of newly synthesized cachectin/tumor necrosis factor in endotoxin-stimulated macrophages. Biochemistry. 1990;29(36):8371–8377
  59. Tosato G, Seamon KB, Goldman ND, Sehgal PB, May LT, Washington GC, et al. Monocyte-derived human B-cell growth factor identified as interferon- beta 2 (BSF-2, IL-6). Science. 1988;239(4839):502–504
  60. Assenmacher M, Lohning M, Scheffold A, Manz RA, Schmitz J, Radbruch A. Sequential production of IL-2, IFN-gamma and IL-10 by individual staphylococcal enterotoxin B-activated T helper lymphocytes. Eur J Immunol. 1998;28(5):1534–1543
  61. Aderem AA, Rosen A, Barker KA. Modulation of prostaglandin and leukotriene biosynthesis. Curr Opin Immunol. 1988;1(1):56–62
  62. Fernando LP, Fernando AN, Ferlito M, Halushka PV, Cook JA. Suppression of Cox-2 and TNF-alpha mRNA in endotoxin tolerance: effect of cycloheximide, antinomycin D, and okadaic acid. Shock. 2000;14(2):128–133
  63. Seki E, Tsutsui H, Tsuji NM, Hayashi N, Adachi K, Nakano H, et al. Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes in mice. J Immunol. 2002;169(7):3863–3868
  64. Ayala A, Chaudry IH. Platelet activating factor and its role in trauma, shock, and sepsis. New Horiz. 1996;4(2):265–275
  65. Lopez-Aguirre Y, Paramo JA. Endothelial cell and hemostatic activation in relation to cytokines in patients with sepsis. Thromb Res. 1999;94(2):95–101
  66. Maruyama I. Biology of endothelium. Lupus. 1998;7(Suppl 2):S41–S43
  67. Huang K, Fishwild DM, Wu HM, Dedrick RL. Lipopolysaccharide-induced E-selectin expression requires continuous presence of LPS and is inhibited by bactericidal/permeability-increasing protein. Inflammation. 1995;19(3):389–404
  68. Hauser IA, Johnson DR, Madri JA. Differential induction of VCAM-1 on human iliac venous and arterial endothelial cells and its role in adhesion. J Immunol. 1993;151(10):5172–5185
  69. Spiecker M, Darius H, Liao JK. A functional role of I kappa B-epsilon in endothelial cell activation. J Immunol. 2000;164(6):3316–3322
  70. Scalia R, Armstead VE, Minchenko AG, Lefer AM. Essential role of P-selectin in the initiation of the inflammatory response induced by hemorrhage and reinfusion. J Exp Med. 1999;189(6):931–938
  71. Pearson PJ, Lin PJ, Schaff HV. Production of endothelium-derived contracting factor is enhanced after coronary reperfusion. Ann Thorac Surg. 1991;51(5):788–793
  72. Graeve L, Baumann M, Heinrich PC. Interleukin-6 in autoimmune disease. Role of IL-6 in physiology and pathology of the immune defense. Clin Invest. 1993;71(8):664–671
  73. Gill EA, Imaizumi T, Carveth H, Topham MK, Tarbet EB, McIntyre TM, et al. Bacterial lipopolysaccharide induces endothelial cells to synthesize a degranulating factor for neutrophils. FASEB J. 1998;12(9):673–684
  74. Derfalvi B, Igaz P, Fulop KA, Szalai C, Falus A. Interleukin-6-induced production of type II acute phase proteins and expression of junB gene are downregulated by human recombinant growth hormone in vitro. Cell Biol Int. 2000;24(2):109–114
  75. Ray A, Hannink M, Ray BK. Concerted participation of NF-kappa B and C/EBP heteromer in lipopolysaccharide induction of serum amyloid A gene expression in liver. J Biol Chem. 1995;270(13):7365–7374
  76. Gibson FC, Onderdonk AB, Kasper DL, Tzianabos AO. Cellular mechanism of intraabdominal abscess formation by Bacteroides fragilis. J Immunol. 1998;160(10):5000–5006
  77. Ferlito M, Romanenko OG, Ashton S, Squadrito F, Halushka PV, Cook JA. Effect of cross-tolerance between endotoxin and TNF-alpha or IL-1beta on cellular signaling and mediator production. J Leukoc Biol. 2001;70(5):821–829
  78. Bonizzi G, Piette J, Merville MP, Bours V. Distinct signal transduction pathways mediate nuclear factor-kappaB induction by IL-1beta in epithelial and lymphoid cells. J Immunol. 1997;159(11):5264–5272
  79. Glynne PA, Evans TJ. Inflammatory cytokines induce apoptotic and necrotic cell shedding from human proximal tubular epithelial cell monolayers. Kidney Int. 1999;55(6):2573–2597
  80. Dinarello CA, Cannon JG, Wolff SM, Bernheim HA, Beutler B, Cerami A, et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med. 1986;163(6):1433–1450
  81. Raivich G, Bohatschek M, Werner A, Jones LL, Galiano M, Kloss CU, et al. Lymphocyte infiltration in the injured brain: Role of proinflammatory cytokines. J Neurosci Res. 2003;72(6):726–733
  82. Espinosa E, Bermúdez-Rattoni F. Behavior-immunity relationship: the role of cytokines. Rev Invest Clin. 2001;53(3):240–253
  83. Dantzer R, Konsman JP, Bluthe RM, Kelley KW. Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent?. Auton Neurosci. 2000;85(1-3):60–65
  84. Zentella A, Manogue K, Cerami A. The role of cachectin/TNF and other cytokines in sepsis. Prog Clin Biol Res. 1991;367:9–24
  85. Blatteis CM. The afferent signalling of fever. J Physiol. 2000;526Pt 3:470
  86. Wang ZQ, Bapat AS, Rayanade RJ, Dagtas AS, Hoffmann MK. Interleukin-10 induces macrophage apoptosis and expression of CD16 (FcgammaRIII) whose engagement blocks the cell death programme and facilitates differentiation. Immunology. 2001;102(3):331–337
  87. Smith WB, Noack L, Khew-Goodall Y, Isenmann S, Vadas MA, Gamble JR. Transforming growth factor-beta 1 inhibits the production of IL-8 and the transmigration of neutrophils through activated endothelium. J Immunol. 1996;157(1):360–368
  88. Celada A, Gray PW, Rinderknecht E, Schreiber RD. Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity. J Exp Med. 1984;160(1):55–74
  89. Hume DA, Underhill DM, Sweet MJ, Ozinsky AO, Liew FY, Aderem A. Macrophages exposed continuously to lipopolysaccharide and other agonists that act via toll-like receptors exhibit a sustained and additive activation state. BMC Immunol. 2001;2(1):11
  90. Cummings CJ, Martin TR, Frevert CW, Quan JM, Wong VA, Mongovin SM, et al. Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis. J Immunol. 1999;162(4):2341–2346
  91. Mantovani A. Chemokines. Introduction and overview. Chem Immunol. 1999;72:1–6
  92. Chandrasekar B, Mummidi S, Perla RP, Bysani S, Dulin NO, Liu F, et al. Fractalkine (CX3CL1) stimulated by NF-kappaB-dependent inflammatory signals induces aortic smooth muscle cells proliferation through an autocrine pathway. Biochem J. 2003;373(Pt 2):547–558
  93. Dejana E, Corada M, Lampugnani MG. Endothelial cell-to-cell junctions. FASEB J. 1995;9(10):910–918
  94. Dejana E, Del Maschio A. Molecular organization and functional regulation of cell to cell junctions in the endothelium. Thromb Haemost. 1995;74(1):309–312
  95. Worrall NK, Chang K, LeJeune WS, Misko TP, Sullivan PM, Ferguson TB, et al. TNF-alpha causes reversible in vivo systemic vascular barrier dysfunction via NO-dependent and -independent mechanisms. Am J Physiol. 1997;273(6 Pt 2):H2565–H2574
  96. Anrather D, Millan MT, Palmetshofer A, Robson SC, Geczy C, Ritchie AJ, et al. Thrombin activates nuclear factor-kappaB and potentiates endothelial cell activation by TNF. J Immunol. 1997;159(11):5620–5628
  97. Carraway MS, Welty-Wolf KE, Miller DL, Ortel TL, Idell S, Ghio AJ, et al. Blockade of tissue factor: treatment for organ injury in established sepsis. Am J Respir Crit Care Med. 2003;167(9):1200–1209
  98. Jaffe EA. Cell biology of endothelial cells. Hum Pathol. 1987;18(3):234–239
  99. Drouet L. Venous thromboembolic pathology. Arch Mal Coeur Vaiss. 2001;94(11 Suppl):1318–1326
  100. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA, et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest. 1995;96(1):60–68
  101. Johns DG, Webb RC. TNF-alpha-induced endothelium-independent vasodilation: A role for phospholipase A2-dependent ceramide signaling. Am J Physiol. 1998;275(5 Pt 2):H1592–H1598
  102. Colwell J. Pathogenesis of vascular disease. Diabetes Obes Metab. 2000;2Suppl 2:S19–S24
  103. Marrero MB, Venema VJ, Ju H, He H, Liang H, Caldwell RB, et al. Endothelial nitric oxide synthase interactions with G-protein-coupled receptors. Biochem J. 1999;343(Pt 2):335–340
  104. Li H, Forstermann U. Nitric oxide in the pathogenesis of vascular disease. J Pathol. 2000;190(3):244–254
  105. Zhou M, Wang P, Chaudry IH. Endothelial nitric oxide synthase is downregulated during hyperdynamic sepsis. Biochim Biophys Acta. 1997;1335(1-2):182–190
  106. Parratt JR. Nitric oxide in sepsis and endotoxaemia. J Antimicrob Chemother. 1998;41(Suppl A):31–39
  107. Galley HF, Nelson SJ, Dhillon J, Dubbels AM, Webster NR. Effect of the nitric oxide inhibitor, L-N(G)-monomethylarginine, on accumulation of interleukin-6 and interleukin-8, and nuclear factor-kappaB activity in a human endothelial cell line. Crit Care Med. 1999;27(5):908–912
  108. Stoclet JC, Martinez MC, Ohlmann P, Chasserot S, Schott C, Kleschyov AL, et al. Induction of nitric oxide synthase and dual effects of nitric oxide and cyclooxygenase products in regulation of arterial contraction in human septic shock. Circulation. 1999;100(2):107–112
  109. Blanco JC, Contursi C, Salkowski CA, DeWitt DL, Ozato K, Vogel SN. Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon gamma-dependent cyclooxygenase 2 expression. J Exp Med. 2000;191(12):2131–2144
  110. Tracey KJ, Morgello S, Koplin B, Fahey TJ, Fox J, Aledo A, et al. Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia. J Clin Invest. 1990;86(6):2014–2024
  111. Baker SJ, Reddy EP. Modulation of life and death by the TNF receptor superfamily. Oncogene. 1998;17(25):3261–3270
  112. Kumar A, Thota V, Dee L, Olson J, Uretz E, Parrillo JE. Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med. 1996;183(3):949–958
  113. Meldrum DR. Tumor necrosis factor in the heart. Am J Physiol. 1998;274(3 Pt 2):R577–R595
  114. Tracey KJ, Cerami A. Metabolic responses to cachectin/TNF. A brief review. Ann NY Acad Sci. 1990;587:325–331
  115. Calvin JW. Thoracoscopy and intrathoracic extrapleural lipoma. Chest. 1977;71(1):121
  116. Maitra SR, Wojnar MM, Lang CH. Alterations in tissue glucose uptake during the hyperglycemic and hypoglycemic phases of sepsis. Shock. 2000;13(5):379–385
  117. McCallum RE. Hepatocyte-Kupffer cell interactions in the inhibition of hepatic gluconeogenesis by bacterial endotoxin. Prog Clin Biol Res. 1981;62:99–113
  118. Zentella A, Manogue K, Cerami A. Cachectin/TNF-mediated lactate production in cultured myocytes is linked to activation of a futile substrate cycle. Cytokine. 1993;5(5):436–447
  119. Gellerich FN, Trumbeckaite S, Hertel K, Zierz S, Muller-Werdan U, Werdan K, et al. Impaired energy metabolism in hearts of septic baboons: diminished activities of Complex I and Complex II of the mitochondrial respiratory chain. Shock. 1999;11(5):336–341
  120. Vary TC, Hazen SA, Maish G, Cooney RN. TNF binding protein prevents hyperlactatemia and inactivation of PDH complex in skeletal muscle during sepsis. J Surg Res. 1998;80(1):44–51
  121. Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology. 2000;32(4 Pt 1):734–739
  122. Oertli B, Beck-Schimmer B, Fan X, Wuthrich RP. Mechanisms of hyaluronan-induced up-regulation of ICAM-1 and VCAM-1 expression by murine kidney tubular epithelial cells: hyaluronan triggers cell adhesion molecule expression through a mechanism involving activation of nuclear factor-kappa B and activating protein-1. J Immunol. 1998;161(7):3431–3437
  123. Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. 1985;229(4716):869–871
  124. Opal SM CJ. Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis?. Crit Care Med. 1999;27(8):1608–1616
  125. Chehab MS. Can we reduce mortality in sepsis?. Saudi Med J. 2004;25(3):277–284
  126. Dhainaut JF YS, Claessens YE. Protein C/activated protein C pathway: overview of clinical trial results in severe sepsis. Crit Care Med. 2004;32(5 Suppl):S194–S201
  127. Murata A. Granulocyte colony-stimulating factor as the expecting sword for the treatment of severe sepsis. Curr Pharm Des. 2003;9(14):1115–1120
  128. Williams DL, Ha T, Li C, Kalbfleisch JH, Laffan JJ, Ferguson DA. Inhibiting early activation of tissue nuclear factor-kappa B and nuclear factor interleukin 6 with (1–>3)-beta-D-glucan increases long-term survival in polymicrobial sepsis. Surgery. 1999;126(1):54–65
  129. Caille VBP, Grimaldi D, Vieillard-Baro A. Physiopathology of severe sepsis. Presse Med. 2004;33(4):256–261
  130. Janssens UGJ. Shock: What are the basics?. Internist (Berl). 2004;45(3):258–266
  131. Cross AS, Opal SM. A new paradigm for the treatment of sepsis: is it time to consider combination therapy?. Ann Intern Med. 2003;138(6):502–505
  132. Opal SM, Cross AS. Clinical trials for severe sepsis. Past failures, and future hopes. Infect Dis Clin North Am. 1999;13(2):285–297vii

 We thank Enrique Espinosa for critical review of the manuscript and encouraging discussions.

PII: S0188-4409(04)00106-7

doi: 10.1016/j.arcmed.2004.07.006

Archives of Medical Research
Volume 35, Issue 6 , Pages 465-479 , November 2004

Article Tools

* Image Usage & Resolution